stock
VRTX · VERTEX PHARMACEUTICALS INC / MA
What VERTEX PHARMACEUTICALS INC / MA reports to the SEC, read from its filings.
Open in the appPrice
The live VRTX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on VRTX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 253,460,924 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 38.0%
- Net
- 35.0%
Returns
- ROE
- 21.8%
- ROA
- 16.1%
Health
- Current ratio
- 3.2x
- Debt/equity
- —
Deep value
- NCAV
- $5.37B
- NCAV per share
- $21.18
- Price/NCAV
- Locked
- NNWC
- $1.45B
- NNWC per share
- $5.73
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $3.33B | —Gross profit: unreported by this company. | $1.25B | $1.10B | 10-Q filed 2026-08-04 |
| 2026-03-31 | $2.99B | —Gross profit: unreported by this company. | $1.14B | $1.03B | 10-Q filed 2026-05-05 |
| 2025-12-31 | $3.19B | —Gross profit: unreported by this company. | $1.21B | $1.19B | 10-K filed 2026-02-13 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $3.08B | —Gross profit: unreported by this company. | $1.19B | $1.08B | 10-Q filed 2025-11-04 |
| 2025-06-30 | $2.96B | —Gross profit: unreported by this company. | $1.15B | $1.03B | 10-Q filed 2026-08-04 |
| 2025-03-31 | $2.77B | —Gross profit: unreported by this company. | $630.10M | $646.30M | 10-Q filed 2026-05-05 |
| 2024-12-31 | $2.91B | —Gross profit: unreported by this company. | $1.03B | $913.00M | 10-K filed 2026-02-13 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $2.77B | —Gross profit: unreported by this company. | $1.12B | $1.05B | 10-Q filed 2025-11-04 |
- Assets
- $27.42B
- Equity
- $20.25B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $12.00B | $4.17B | $3.95B | $3.19B |
| 2024-12-31 | $11.02B | -$232.90M | -$535.60M | -$790.30M |
| 2023-12-31 | $9.87B | $3.83B | $3.62B | $3.34B |
| 2022-12-31 | $8.93B | $4.31B | $3.32B | $3.93B |
| 2021-12-31 | $7.57B | $2.78B | $2.34B | $2.41B |
| 2020-12-31 | $6.21B | $2.86B | $2.71B | $2.99B |
| 2019-12-31 | $4.16B | $1.20B | $1.18B | $1.49B |
| 2018-12-31 | $3.05B | $635.15M | $2.10B | $1.17B |
| 2017-12-31 | $2.49B | $123.24M | $263.48M | $745.52M |
| 2016-12-31 | $1.70B | $9.94M | -$112.05M | $179.54M |
Company filings
events
Executive or director change
Executive or director changeSep 18-KResults
ResultsAug 38-KMaterial agreement, Regulation FD disclosure, Other event
Material agreementRegulation FD disclosureOther eventJul 68-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsMay 138-KResults
ResultsMay 48-KExecutive or director change
Executive or director changeApr 298-K
5% owners ()
Capital World Investors
Stake update
Capital Research Global Investors
Stake update
Vanguard Capital Management
Passive stake
The Vanguard Group
Stake update
Capital Research Global Investors
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
David J. Taylor
House · OH02
Sale$1,001 to $15,000Sat Sep 5
Thomas H Tuberville
Senate
Sale$1,001 to $15,000Wed Aug 5
Alan Armstrong
Senate
Buy$1,001 to $15,000Tue Jul 21
Funds
- Tweedy Browne
Period Tue 30 Jun 2026
1.5%Trimmed - Baillie Gifford
Period Tue 30 Jun 2026
0.1%Added - Bridgewater Associates
Period Tue 30 Jun 2026
0.0%Trimmed - Point72
Calls · Period Tue 30 Jun 2026
0.0%Trimmed - Point72
Period Tue 30 Jun 2026
0.0%New
News
Stories that named VRTX, and the market events around them.
Sign in to see thisBoard
The VRTX board could not be loaded.
Retry the VRTX boardnakagai
Signals on VRTX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the VRTX board